ATE305777T1 - Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation - Google Patents

Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation

Info

Publication number
ATE305777T1
ATE305777T1 AT00944318T AT00944318T ATE305777T1 AT E305777 T1 ATE305777 T1 AT E305777T1 AT 00944318 T AT00944318 T AT 00944318T AT 00944318 T AT00944318 T AT 00944318T AT E305777 T1 ATE305777 T1 AT E305777T1
Authority
AT
Austria
Prior art keywords
agent
organ transplantation
chronic rejection
result
rejection reaction
Prior art date
Application number
AT00944318T
Other languages
English (en)
Inventor
Mitsuaki Isobe
Atsushi Izawa
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Application granted granted Critical
Publication of ATE305777T1 publication Critical patent/ATE305777T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AT00944318T 1999-07-16 2000-07-07 Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation ATE305777T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20327099 1999-07-16
PCT/JP2000/004529 WO2001005394A1 (fr) 1999-07-16 2000-07-07 Agents inhibant les reactions de rejet chronique faisant suite a une greffe d'organe

Publications (1)

Publication Number Publication Date
ATE305777T1 true ATE305777T1 (de) 2005-10-15

Family

ID=16471275

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00944318T ATE305777T1 (de) 1999-07-16 2000-07-07 Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation

Country Status (6)

Country Link
US (1) US6552083B1 (de)
EP (1) EP1197210B1 (de)
AT (1) ATE305777T1 (de)
DE (1) DE60023008T2 (de)
ES (1) ES2250154T3 (de)
WO (1) WO2001005394A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
WO2005041655A1 (en) * 2003-10-22 2005-05-12 Fred Hutchinson Cancer Research Center Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
US20050170019A1 (en) * 2003-10-22 2005-08-04 Fred Hutchinson Cancer Research Center Methods, compositions and devices for inducing stasis in cells
US20050136125A1 (en) * 2003-10-22 2005-06-23 Roth Mark B. Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
WO2006073126A1 (ja) * 2005-01-06 2006-07-13 Kissei Pharmaceutical Co., Ltd. 慢性移植片対宿主症におけるドライアイの予防および治療剤
PT1879599E (pt) * 2005-04-20 2014-01-23 Hutchinson Fred Cancer Res Métodos, composições e artigos de fabrico para aumentar a capacidade de sobrevivência de células, tecidos, órgãos, e organismos
WO2007043641A1 (ja) * 2005-10-14 2007-04-19 Fukuoka University 膵島移植における移植膵島障害抑制剤
AU2006305119B2 (en) 2005-10-21 2012-12-20 Chugai Seiyaku Kabushiki Kaisha Agents for treating cardiopathy
AR057582A1 (es) 2005-11-15 2007-12-05 Nat Hospital Organization Agentes para suprimir la induccion de linfocitos t citotoxicos
WO2007061029A1 (ja) * 2005-11-25 2007-05-31 Keio University 前立腺癌治療剤
CN101370521A (zh) 2006-01-27 2009-02-18 学校法人庆应义塾 伴有脉络膜血管生成的疾病的治疗药
CA2648644C (en) 2006-04-07 2016-01-05 Osaka University Muscle regeneration promoter
US20080089947A1 (en) * 2006-08-18 2008-04-17 Knox Clayton D Calcium Influx Inhibitors in the Treatment of Ischemia
CN101646459B (zh) * 2007-01-23 2014-02-12 国立大学法人信州大学 慢性排斥反应抑制剂
TWI528973B (zh) 2008-06-05 2016-04-11 Chugai Pharmaceutical Co Ltd Nerve infiltration inhibitor
EP2455077B1 (de) 2009-06-17 2014-06-11 National University Corporation Kumamoto University Prophylaxe- und/oder behandlungsmittel für dysmenorrhoe
RS63800B1 (sr) 2010-05-28 2022-12-30 Chugai Pharmaceutical Co Ltd Poboljšanje antitumorskog odgovora t ćelije
CN102770132B (zh) * 2010-12-08 2015-05-27 李先亮 苯甲酸衍生物的药物用途
CN107249593A (zh) * 2014-11-06 2017-10-13 达纳-法伯癌症研究所股份有限公司 调节染色质结构的组合物用于移植物抗宿主疾病(gvhd)的用途
US11851486B2 (en) 2017-05-02 2023-12-26 National Center Of Neurology And Psychiatry Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils
EP3698808A4 (de) 2017-10-20 2021-07-14 Hyogo College Of Medicine Anti-il-6 rezeptorantikörper enthaltende medizinische zusammensetzung zur verhinderung von postoperativer adhäsion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (ja) 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤

Also Published As

Publication number Publication date
EP1197210A4 (de) 2005-02-16
DE60023008T2 (de) 2006-07-06
ES2250154T3 (es) 2006-04-16
DE60023008D1 (de) 2006-02-16
WO2001005394A1 (fr) 2001-01-25
EP1197210A1 (de) 2002-04-17
EP1197210B1 (de) 2005-10-05
US6552083B1 (en) 2003-04-22

Similar Documents

Publication Publication Date Title
ATE305777T1 (de) Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation
NO20050309L (no) Nye komplekser av fettsyreestere av polyhydroksyalkan- og pyridinkarboksyderivater
DE60140491D1 (de) Verwendung einer pharmazeutischen Zusammensetzung mit einem Para-Aminophenylessigsäurederivat für die Behandlung von entzündlichen Erkrankungen des Magen-Darmtrakts
RS52625B (en) FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
BG106158A (en) New use of compounds as antibacterial agents
HRP20060286T3 (en) Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
DE502004006619D1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
DE602004011255D1 (de) Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
SI1970372T1 (sl) Soli 9-oksoakridin-10-ocetne kisline z 1-alkilamino-1-deoksi-polioli
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
BR0112245B1 (pt) Éster de ácido 4-alcóxi-ciclohexano-1-amino-carboxílico
HUP0102678A2 (hu) Peszticid hatású fenil-metoxi-imino-ecetsav-származékok, intermedierjeik előállításuk és alkalmazásuk
BR0314860A (pt) Derivados de pirazol
WO2000066094A3 (de) Verwendung von verbindungen mit einem stickstoff-sauerstoff-heterocyclus als antiinfektiöse mittel
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
ATE360423T1 (de) Verwendung von chymase hemmern gegen vaskuläre lipidablagerung
DE602005017629D1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
EA200100586A1 (ru) Применение производных фосфономуравьиной кислоты для лечения инфекций
NO20070421L (no) Radiosensitiviserende middel
DE60003671D1 (de) Halo-derivate von 9-deoxo-9a-aza-9a-homerythromycin a
DE60319254D1 (de) Pyrazolamide zur behandlung von hiv-infektionen
EP1310498A3 (de) Pyrazoloquinolinonderivative als Proteinkinase-C-Hemmer
HUP0303174A2 (hu) A terbinafin almasav addíciós sói, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ATE505193T1 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
EA200100585A1 (ru) Применение производных фосфономуравьиной кислоты для лечения инфекций

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties